APA (7th ed.) Citation

Shimizu, Y., Kaji, D., Watanabe, O., Yamaguchi, K., Kageyama, K., Taya, Y., . . . Yamamoto, G. (2023). Rituximab/bendamustine/cytarabine for transplant‐eligible patients with mantle cell lymphoma: A retrospective study. Cancer Medicine, 12(11), 12548. https://doi.org/10.1002/cam4.6114

Chicago Style (17th ed.) Citation

Shimizu, Yuki, et al. "Rituximab/bendamustine/cytarabine for Transplant‐eligible Patients with Mantle Cell Lymphoma: A Retrospective Study." Cancer Medicine 12, no. 11 (2023): 12548. https://doi.org/10.1002/cam4.6114.

MLA (9th ed.) Citation

Shimizu, Yuki, et al. "Rituximab/bendamustine/cytarabine for Transplant‐eligible Patients with Mantle Cell Lymphoma: A Retrospective Study." Cancer Medicine, vol. 12, no. 11, 2023, p. 12548, https://doi.org/10.1002/cam4.6114.